Alzheimer's congress. Drug shows promise for advanced disease.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium: Print ISSN: 0036-8075 (Print) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

Publication: : Washington, DC : American Association for the Advancement of Science
Original Publication: New York, N.Y. : [s.n.] 1880-

Alzheimer Disease/*drug therapy ; Excitatory Amino Acid Antagonists/*therapeutic use ; Memantine/*therapeutic use; Disease Progression ; Excitatory Amino Acid Antagonists/adverse effects ; Humans ; Memantine/adverse effects ; Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors ; Receptors, N-Methyl-D-Aspartate/metabolism ; United States

Comment in: Science. 2000 Aug 11;289(5481):869. (PMID: 10960316)

0 (Excitatory Amino Acid Antagonists)
0 (Receptors, N-Methyl-D-Aspartate)
W8O17SJF3T (Memantine)

Date Created: 20000812 Date Completed: 20000804 Latest Revision: 20210928

20240627

10.1126/science.289.5478.375b

10939942